Our team approach helps to ensure the most comprehensive, quality care for patients. In weekly multidisciplinary meetings and daily grand rounds, we carefully plan each patient’s treatment and how to best meet his or her particular needs.
Our nursing staff consists of more than 60 registered nurses, many of whom are oncology-certified and specifically trained in critical care. Nurse clinicians, certified nurse practitioners, research nurses, transplant coordinators, pharmacists, social workers, clinical psychologists, physical therapists, patient care assistants, dietitians and chaplains are all part of our experienced team and are dedicated to each and every patient’s success.
Our Physicians
 |
James Essell, MDDr. James Essell, is the Medical Director of the Blood Cancer Center at The Jewish Hospital – Mercy Health and has been with Jewish Hospital’s Blood Cancer Center since 1997. Treating the patient, not solely the cancer, is the focus of the medical practice of James H. Essell, M.D. “I am with my patients throughout their journeys with cancer, and treat every patient as if he or she is a member of my own family.” Dr. Essell is board certified in internal medicine, hematology, and medical oncology. After graduating from medical school at the University of Cincinnati College of Medicine, he completed a residency and a fellowship at Wilford Hall USAF Medical Center. Hematologic malignancies, benign hematology, and sarcoma are areas of interest for Dr. Essell. “Many of my family members have had cancer. As a physician, I want to make a difference. Cancer and the treatments for cancer can affect anyone and certainly affect all parts of the body, which makes for a challenging career.” |
 |
Dr. E. Randolph BrounE. Randolph Broun, MD has been with the Blood Cancer Center since 1996. Dr. Broun’s specialties are hematologic malignancies and bone marrow transplant. Of particular interest is the use of alternative donors in bone marrow transplant. After graduating from the St. Louis University School of Medicine, he completed Internal Medicine Residency at Indiana University and was Chief Resident in Medicine. He then completed Hematology Oncology fellowship at University of Texas – San Antonio and a fellowship in Bone Marrow Transplantation at Indiana University. He is Board Certified in Internal Medicine and Medical Oncology. Before coming to Cincinnati, Dr. Broun served as director of the Bone Marrow Transplant Programs at St. Louis University Health Sciences Center and at Indiana University. He was also Medical Director of the Indiana University Hematology/Oncology Unit. He has numerous publications in the area of Blood and Marrow Transplant and Hematologic Malignancies. |
 |
Miguel Islas-Ohlmayer, MDDr. Islas-Ohlmayer has been with the Blood Cancer Center since 2010. He has a passion for helping patients who are dealing with difficult situations. “I want to help those with the most challenging conditions, such as leukemia.” Board certified in hematology and internal medicine, his specialties are medical oncology and hematology. He has a particular interest in hematologic malignancies and blood and marrow stem cell transplantation. After graduating from medical school at the Universidad de Monterrey School of Medicine, he completed a residency at Valley Baptist Medical Center/University of Texas Health Center. Dr. Islas-Ohlmayer also completed fellowships at the University of Texas Southwestern Medical Center and the University of Texas Health Science Center/Texas Transplant Institute. |
 |
Edward A. Faber, Jr., MDDr. Faber recently joined our Blood Cancer Center team in July 2013. Dr. Faber received a B.Sc. degree from Allegheny College, a M.S. degree from Duquesne University, and a D.O. degree from Lake Erie College of Osteopathic Medicine. He completed internship and residency at University of Pittsburgh Medical Center (UPMC) – Mercy Hospital, followed by fellowship in hematology/oncology at Michigan State University. Dr. Faber is board certified through the American Board of Internal Medicine in Internal Medicine, Hematology, and Medical Oncology. Prior to joining the Blood Cancer Center team, Dr. Faber was Assistant Professor of Medicine at the University of Nebraska Medical Center (UNMC). He treated both malignant hematology (blood cancers) and benign hematology (bleeding and clotting disorders), as well as bone marrow transplantation patients. Dr. Faber's special, focused interests centered on multiple myeloma, amyloid, and Waldenstrom patients, as well as a general interest in leukemia and lymphoma patients. He directed a comprehensive, multidisciplinary program for multiple myeloma, accepted as a Center of Excellence for the care of multiple myeloma patients. Dr. Faber was also the Director of UNMC’s Hematology/Oncology Course and participated on the Hematology/Oncology Fellowship Committee. Dr. Faber served as a Multiple Myeloma and Waldenstrom’s Macroglobulinemia panel member for the National Comprehensive Cancer Network (NCCN). He also served as the National Physician Advisor for the education project of the Association of Community Cancer Centers (ACCC])Improving Quality Care for Multiple Myeloma. Dr. Faber continues to participate as a member of the Myeloma and Transplant Committees for the Alliance for Clinical Trials in Oncology, the Plasma Cell Disorders Working Committee of CIBMTR, and the Myeloma Committee for the BMT CTN. Finally, he also continues to serve as an Advisory Panelist for Amyloidosis on ASCO’s Cancer.Net Editorial Board. Dr. Faber continues to collaborate with basic science researchers at UNMC and the University of North Carolina to develop a new therapy that can overcome drug resistance in relapsed/refractory myeloma patients. In addition to Dr. Faber's abstract, web-based, manuscript and book chapter publications, he was nominated as the “Man of the Year” by the Leukemia & Lymphoma Society in 2013 and was also named “Resident of the Year” in the final year of his Internal Medicine Residency. |